Seogsong Jeong

Dr. Seogsong Jeong


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
SHSeo Yun Hwang
Seo Yun Hwang
SJSeogsong Jeong
Seogsong Jeong
SCSeulggie Choi
Seulggie Choi
DKDong Hyun Kim
Dong Hyun Kim
SKSeong Rae Kim
Seong Rae Kim
SPSang Min Park
Sang Min Park
(1) Background: There is limited information regarding association between long-term exposure to air pollutants and risk of chronic kidney disease (CKD) (2). Methods: This study acquired data of 164,093 adults aged at least 40 years who were residing in 7 metropolitan cities between 2002 and 2005 from the Korean National Health Insurance Service National Sample Cohort database. CKD risk was evaluated using the multivariate Cox hazards proportional regression. All participants were followed up with until CKD, death, or 31 December 2013, whichever occurred earliest. (3) Results: Among 1,259,461 person-years of follow-up investigation, CKD cases occurred in 1494 participants. Air pollutant exposures including PM10, SO2, NO2, CO, and O3 showed no significant association with incident CKD after adjustments for age, sex, household income, area of residence, and the Charlson comorbidity index. The results were consistent in the sensitivity analyses including first and last year annual exposure analyses as well as latent periods-washed-out analyses. (4) Conclusions: Long-term exposure to air pollution is not likely to increase the risk of CKD.

16 March 2021 in Research Square
Verified
Preprint
Open access
PDF file
SJSeogsong Jeong
Seogsong Jeong
YOYun Hwan Oh
Yun Hwan Oh
SCSeulggie Choi
Seulggie Choi
JCJooyoung Chang
Jooyoung Chang
SKSung Min Kim
Sung Min Kim
SPSang Min Park
Sang Min Park
Background/purpose: Metabolic dysfunction (MD)-associated fatty liver disease (MAFLD) is new clearer nomenclature with positive diagnostic criteria on the basis of hepatic steatosis and MD, involving exclusion criteria for nonalcoholic fatty liver disease (NAFLD).Methods: This retrospective cohort study included 333,389 participants who received health examination between 2009 and 2010 from the Korean National Health Insurance Service database. Hepatic steatosis was defined using the Korean National Health and Nutrition Examination Survey-derived NAFLD scoring system. Participants were followed over 5-6 years from the index date of health examination to 31 December 2015 for cardiovascular disease (CVD). The Cox proportional hazards regression was adopted to determine adjusted hazard ratio (aHR) with 95% confidence interval (CI) for CVD according to the presence of hepatic steatosis, MD, and MAFLD.Results: This study included 179,437 men and 153,952 women with a median age of 57 years. Hepatic steatosis with MD (aHR, 2.00; 95% CI, 1.89-2.13) and without MD (aHR, 1.30; 95% CI, 1.10-1.54) significantly increased the risk of CVD compared to no steatosis without MD (reference). However, steatosis revealed no significant difference in the risk of CVD compared to no steatosis among participants with one metabolic dysfunction (aHR, 1.09; 95% CI, 0.91-1.30). In participants with steatosis, the presence of one and ≥2 metabolic dysfunctions had aHR of 1.25 (95% CI, 0.87-1.79) and 1.71 (95% CI, 1.22-2.41) compared to no MD, respectively.Conclusion: MAFLD was significantly associated with increased CVD risk and had better predictive performance for CVD risk compared to hepatic steatosis or metabolic dysfunction alone.